CJC-1295 No-DAC Research Peptide

Direct Anti Peptide is proud to offer CJC-1295 No-DAC, a high-purity synthetic GHRH analogue trusted by research institutions worldwide. Produced to ≥98% purity and rigorously verified through HPLC and mass spectrometry, this peptide is available for sale online with fast, reliable fulfillment. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

CJC-1295 No-DAC (without Drug Affinity Complex) is a synthetic peptide analogue of endogenous growth hormone-releasing hormone (GHRH). Unlike its longer-acting counterpart, this variant lacks the Drug Affinity Complex modification, resulting in a significantly shorter half-life and a more pulsatile release profile that closely mirrors natural physiological GHRH activity. These characteristics make CJC-1295 No-DAC a compelling research tool for scientists investigating growth hormone secretion dynamics, metabolic signalling pathways, and related endocrine mechanisms. Researchers seeking to buy CJC-1295 No-DAC online will find Direct Anti Peptide a reliable source offering competitive pricing and consistent quality.

Peptide Structure & Amino Acid Sequence

CJC-1295 No-DAC is a 29-amino-acid peptide analogue derived from the first 29 residues of endogenous GHRH(1-29)-NH₂. Its sequence has been strategically modified to improve receptor binding affinity and resistance to enzymatic degradation compared to native GHRH, while retaining a physiologically relevant half-life in the range of approximately 30 minutes. The absence of the lysine-maleimide DAC linker distinguishes this peptide structurally from CJC-1295 with DAC and is central to its distinct pharmacokinetic research profile.

Chemical & Physical Characteristics

• Peptide Type: Synthetic GHRH analogue
• Amino Acids: 29-residue modified sequence
• Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Molecular Weight: Approximately 3,367.9 Da
• Appearance: White to off-white lyophilised powder
• Solubility: Soluble in aqueous buffer solutions under laboratory conditions
• Half-Life Profile: Short-acting, pulsatile GHRH mimetic
• Purity: ≥98% as confirmed by analytical HPLC

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 No-DAC supplied by Direct Anti Peptide undergoes stringent analytical testing before release. Reverse-phase high-performance liquid chromatography (RP-HPLC) is employed to confirm a minimum purity of ≥98%, ensuring that researchers receive a compound free from significant peptide-related impurities. Mass spectrometry (MS) validation is additionally performed to verify the correct molecular weight and sequence integrity of each production lot. These dual verification methods provide the analytical confidence required for reproducible and publication-quality research outcomes.

Quality Control & Lyophilisation Integrity

CJC-1295 No-DAC is produced under tightly controlled manufacturing conditions consistent with peptide synthesis best practices. Following synthesis and purification, the peptide undergoes lyophilisation (freeze-drying) to produce a stable, moisture-free powder that maintains structural and chemical integrity during storage and transit. Each vial is sealed under inert conditions to minimise oxidative degradation. Lot-specific certificates of analysis (CoA) are available and confirm that every unit dispatched meets the stated ≥98% purity specification.

Safety, Handling & Laboratory Precautions

CJC-1295 No-DAC is intended solely for use by trained scientific professionals operating within appropriately equipped laboratory environments. Researchers should consult relevant safety data and institutional guidelines before handling this compound. Standard laboratory precautions apply, including the use of appropriate personal protective equipment (PPE). This peptide must not be administered to humans or animals under any circumstances. Keep out of reach of unauthorised personnel.

Reconstitution, Packaging & Storage

CJC-1295 No-DAC is supplied as a lyophilised powder in sealed, individually labelled research vials. For optimal stability, store lyophilised vials at −20°C in a dry, dark environment away from repeated freeze-thaw cycles. Reconstitution should be performed using appropriate sterile laboratory-grade solvents in accordance with established research protocols and is intended strictly for in vitro or preclinical research applications. Once reconstituted, solutions should be aliquoted promptly and stored according to validated laboratory procedures. Refer to your institutional SOPs for specific handling guidance.

Intended Research Use & Market Positioning

CJC-1295 No-DAC has attracted significant attention within the scientific research community for its utility in studying endogenous growth hormone secretion, pituitary receptor activation, metabolic regulation, and body composition research models. Its shorter half-life relative to DAC-modified variants makes it particularly valuable for experiments requiring tightly controlled, time-resolved hormonal stimulation protocols. Direct Anti Peptide positions this compound as a premium-grade, analytically verified research reagent for sale to qualified investigators, academic institutions, and licensed research facilities.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers CJC-1295 No-DAC for sale online with straightforward ordering, transparent pricing, and prompt dispatch. Whether you are looking to order a single research vial or require bulk quantities for extended study programmes, our fulfilment infrastructure is designed to support your laboratory’s needs efficiently. Bulk purchase options are available at discounted rates, providing researchers with the best price without compromising on analytical quality. Order now through our secure platform and benefit from fast shipping to most international destinations.

Legal & Regulatory Disclaimer

CJC-1295 No-DAC is supplied by Direct Anti Peptide strictly as a laboratory research reagent. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the procurement, storage, and use of research peptides. Direct Anti Peptide accepts no liability for misuse or use outside the intended research context.